Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)
Launched by MANCHESTER UNIVERSITY NHS FOUNDATION TRUST · May 28, 2020
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Work Stream A (in-hospital; Group 1 and Group 2):
- Group 1 Inclusion Criteria:
- We will include participants (patients or staff):
- • 1. That are 18 years or older
- • 2. That will require testing for COVID-19 in the opinion of the treating clinician
- • 3. That may have presented with acute symptoms of COVID-19 (e.g. fever, cough, dyspnoea, anosmia) or chest x-ray changes or they may be asymptomatic but require testing for other reasons
- Group 2 Inclusion Criteria:
- We will include participants:
- • 1. That are 18 years or older
- • 2. That have been admitted for another reason other than suspected SARS-CoV-2 infection, but when routinely swabbed they have been identified as positive for SARS-CoV-2 PCR
- Work Stream B (Group 3):
- We will include participants:
- • 1. That are 18 years or older
- EITHER:
- • 2. They have been identified as positive for SARS-CoV-2 PCR through testing at national laboratory infrastructure OR
- • 3. They have been identified as negative for SARS-CoV-2 PCR through testing at national laboratory infrastructure
- Work Stream C (Group 4):
- We will include participants:
- • 1. That are 18 years or older
- • 2. Who are undergoing testing for COVID-19, whether they are symptomatic or symptomatic for COVID-19
- Exclusion Criteria for all Work Streams:
- • 1. Patients where it is impossible/unsafe to obtain the required research samples
- • 2. Prisoners
- • 3. Patients where sampling is not feasible
About Manchester University Nhs Foundation Trust
Manchester University NHS Foundation Trust is a leading healthcare organization dedicated to delivering exceptional patient care and advancing medical research. As an integral part of the UK's National Health Service, the Trust encompasses a range of hospitals and services, fostering innovation in clinical research and trials. With a strong emphasis on collaboration and excellence, Manchester University NHS Foundation Trust is committed to improving health outcomes through rigorous scientific investigation and the translation of research findings into practice, ensuring that patients benefit from the latest advancements in medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, , United Kingdom
Stoke On Trent, , United Kingdom
Birmingham, , United Kingdom
Derby, , United Kingdom
Frimley, , United Kingdom
Keighley, , United Kingdom
Leeds, , United Kingdom
London, , United Kingdom
Manchester, , United Kingdom
Newcastle Upon Tyne, , United Kingdom
Oxford, , United Kingdom
Reading, , United Kingdom
Romford, , United Kingdom
Salford, , United Kingdom
Southampton, , United Kingdom
Patients applied
Trial Officials
Richard Body
Study Director
Manchester University NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials